Company intelligence / Profile preview

MedWay Group

Ownership: Private
Employees: ~19
Development stage: Commercial

Overview

The company provides a broad portfolio of advanced wound care dressings—including collagens, alginates, hydrocolloids, foams and silicone foams—as well as nano-silver-based wound wash/dressing gel. Their solutions target improved patient outcomes and cost efficiency for healthcare providers. No clinical trial data reported; all products appear to be cleared/registered medical devices rather than drugs or investigational therapies.

Therapeutic areas: Dermatology
Modalities: DeviceWound care dressingNano silver wound care productsMattress systems for pressure ulcers
Industry: Consumable Medical Devices

Drug pipeline

4 assets

Jalupro Super Hydro

Commercial

Indications: Dermatology

3 more assets in the full pipeline.

Request access →

Partnerships

Works with clinicians, scientists, business partners globally to develop novel solutions—no specific major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on MedWay Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedWay Group.

Explore the full profile